carrito Compra

(0 Productos)

Gastos de envío GRATIS

Solo para España


WHO REPORTING SYSTEM FOR PANCREATICOBILIARY CYTOPATHOLOGY (IAC-IARC-WHO Cytopathology Reporting Sys)

WHO REPORTING SYSTEM FOR PANCREATICOBILIARY CYTOPATHOLOGY (IAC-IARC-WHO Cytopathology Reporting Sys)-9789283245186
  1. Autor:

    IAC IARC WHO

  2. Isbn:

    9789283245186

  3. Páginas:

    200

  4. Año:

    2023

  5. Edición:

    1

  6. Idioma:

    Ingles

  7. Disponibilidad:

    En Stock

Precio s/iva:
124,04  €
Volver

DESCRIPTION:
The WHO Reporting System for Pancreaticobiliary Cytopathology is Volume 2 of this new series of reporting systems for cytopathology, which is a joint project of the International Academy of Cytology (IAC) and the International Agency for Research on Cancer (IARC), a specialized agency of the World Health Organization (WHO). The series includes a unique synthesis of the published evidence and the practice of cytopathology, and it is linked to the WHO Classification of Tumours series, now in its 5th edition.

Cytopathologists look at tumours slightly differently than other specialists do, and there is a need for specialized reporting systems based on the key diagnostic cytopathological features of tumours, presented in standardized reports, within a hierarchical system of diagnostic categories. These categories must also be linked to diagnostic management recommendations to improve communication with clinicians and support patient care. And it is essential that these reporting systems be truly international, to serve the needs of patients worldwide in many differently medically resourced settings.

WHAT ARE THE KEY FEATURES OF THIS FIRST EDITION OF THE SERIES?
These volumes are an essential tool for standardizing diagnostic cytopathology practice worldwide and will serve as a vehicle for the translation of cytopathology research into practice. The key diagnostic cytopathological features are listed for each tumour type under a defined set of diagnostic categories and described in precise, uniform language.
These diagnostic criteria represent the first international consensus and are underpinned by evidence that has been evaluated and debated by experts in the field. Each lesion-specific section includes a dedicated subsection discussing the differential diagnosis of the cytopathological features that can be used throughout the world, including in low-resource settings, followed by a subsection describing the current best-practice application of ancillary testing (including next-generation sequencing)

CONTENTS:
1. Introduction to the WHO Reporting System for Pancreaticobiliary Cytopathology
Background
The role of pancreaticobiliary cytopathology
Integration of clinical, radiological, and key FNAB cytopathological features with ancillary testing in a diagnostic approach
Diagnostic categories and report structure
Risk of malignancy and management recommendations
2. Pancreaticobiliary cytopathology techniques
Sampling methods and tissue triage FNAB techniques and specimen management for solid pancreatic masses
FNAB techniques and specimen management for pancreatic cysts
FNAB techniques and specimen management for bile duct brushings
Percutaneous FNAB and specimen management
Rapid onsite evaluation
Ancillary testing
Introduction: The role of ancillary testing
Immunocytochemistry
In situ hybridization
Molecular testing
Biochemical testing of cyst fluid
3. Diagnostic category: Insufficient/Inadequate/Non-diagnostic
Introduction
Definition
Discussion and background
Risk of malignancy and management recommendations
Sample reports
4. Diagnostic category: Benign / Negative for malignancy
Introduction
Definition
Discussion and background
Risk of malignancy and management recommendations
Benign non-neoplastic processes
Normal pancreatic and biliary parenchyma and contaminants
Acute pancreatitis
Cholangitis
Chronic pancreatitis
Groove/paraduodenal pancreatitis
Autoimmune and IgG4-related pancreatitis
Lymphoepithelial cyst
Pseudocysts
Splenule (accessory spleen)
Benign neoplastic processes
Serous cystadenoma
Schwannoma
Lymphangioma
Other rare benign neoplasms
Sample reports
5. Diagnostic category: Atypical
Introduction
Definition
Discussion and background
Risk of malignancy and management recommendations
Sample reports
6. Diagnostic category: Pancreaticobiliary neoplasm, low-risk/grade
Introduction
Definition
Discussion and background
Risk of malignancy and management recommendations
Specific lesions
Pancreatic intraepithelial neoplasia, low-grade
Biliary intraepithelial neoplasia, low-grade
Pancreatic intraductal papillary mucinous neoplasm, low-grade
Intraductal papillary neoplasm of the bile duct, low-grade
Mucinous cystic neoplasm, low-grade
Other lesions (including spindle cell tumours)
Sample reports
7. Diagnostic category: Pancreaticobiliary neoplasm, high-risk/grade
Introduction
Definition
Discussion and background
Risk of malignancy and management recommendations
Specific lesions
Pancreatic intraepithelial neoplasia, high-grade
Biliary intraepithelial neoplasia, high-grade
Pancreatic intraductal papillary mucinous neoplasm, high-grade
Intraductal papillary neoplasm of the bile duct, high-grade
Mucinous cystic neoplasm, high-grade
Intraductal oncocytic papillary neoplasm
Intraductal tubulopapillary neoplasm
Sample reports
8. Diagnostic category: Suspicious for malignancy
Introduction
Definition
Discussion and background
Risk of malignancy and management recommendations
Sample reports
9 Diagnostic category: Malignant
Introduction
Definition
Discussion and background
Risk of malignancy and management recommendations
Specific lesions
Cholangiocarcinoma
Pancreatic ductal adenocarcinoma
Pancreatic acinar cell carcinoma
Neuroendocrine tumour
Neuroendocrine carcinoma
Pancreatoblastoma
Solid pseudopapillary neoplasm
Pancreatic lymphomas
Metastases to the pancreas
Other lesions (including spindle cell tumours)
Sample reports
10. Management recommendationsfor each diagnostic category
Introduction
Insufficient/Inadequate/Non-diagnostic
Benign / Negative for malignancy
Atypical
Pancreaticobiliary neoplasm, low-risk/grade
Pancreaticobiliary neoplasm, high-risk/grade
Suspicious for malignancy
Malignant
Contributors
Declaration of interests
Sources
References
Subject index
Previous volumes in the series